ABSTRACT
(1) Background: This study aims to comprehensively understand the motivations driving radiographers in five Arab countries to engage in research. (2) Methods: A cross-sectional study employing an anonymous online survey was conducted for 12 weeks from May to July 2023. The study sample consisted of 250 radiographers, with equal representation from Iraq, the Kingdom of Saudi Arabia, Palestine, Sudan, and the United Arab Emirates. (3) Results: Overall, the participants showed limited involvement in research-related activities in all five countries, particularly in presenting at conferences and publishing in peer-reviewed journals. Most participants believed research positively impacts their professional development (34.8%) and patient care and outcomes (40%). The participants perceived professional development (36.4%) as a key motivator for research engagement. A significant majority (81.6%) expressed motivation to start research in clinical practice. A total of 66.8% found research opportunities available during clinical practice. Barriers included time constraints (56%), limited resources (47.2%), and lack of support and skills (33.2% and 32%, respectively). (4) Conclusion: This study emphasises the need for targeted strategies to enhance research engagement among radiographers in the Arab region. Addressing barriers, such as time constraints and resource limitations, while leveraging intrinsic motivators, such as professional development, is crucial for fostering a culture of research-driven excellence in radiography.
ABSTRACT
BACKGROUND: Physiological lip hyperpigmentation (PLH) is a common cosmetic concern in the Middle East and Asia. It is characterized by homogeneous symmetric diffuse hyperpigmentation affecting both lips. There is no satisfactory treatment for this condition. The aim of this study is to evaluate the efficacy and safety of Q-switched (QS) 532 nm Nd:YAG laser for PLH. METHODS: A total of 30 patients with clinical diagnosis of PLH were retrospectively reviewed and included in the study. Patients underwent at least one laser treatment using QS 532 nm with a minimum follow up of six months. Laser parameters were as follows: spot size 2-3 mm, pulse duration 20 ns, fluence 2-4 J/cm2. One to three sessions were performed depending on clinical response. Two methods were used for assessment: patient satisfaction and independent physician assessment. PLH was classified as grade 1 (upper lip fully affected plus only border of lower lip), grade 2 (upper lip fully affected plus most of lower lip), and grade 3 (majority of both lips hyperpigmented). RESULTS: Excellent (>75% improvement) response was achieved in 30% of patients. Good (51-75% improvement) response was seen in 37% and 43% of patients according to patient satisfaction and independent physician assessment, respectively. Majority of patients required only one treatment session. Reactivation of herpes labialis occurred in two patients, and mottled hypopigmentation in three patients. None of the patients developed persistent hyperpigmentation or scarring. CONCLUSIONS: PLH can be effectively treated with QS 532 nm Nd:YAG laser and is well tolerated by patients.
Subject(s)
Hyperpigmentation , Laser Therapy , Lasers, Solid-State , Low-Level Light Therapy , Humans , Hyperpigmentation/etiology , Hyperpigmentation/radiotherapy , Laser Therapy/adverse effects , Laser Therapy/methods , Lasers, Solid-State/adverse effects , Lip , Retrospective Studies , Treatment OutcomeABSTRACT
OBJECTIVE: The aim of this Delphi study was to examine consensus on the appropriateness of the medicines reconciliation (MR) indicators. METHODS: Practising hospital pharmacists in UK hospitals conducting MR in hospital wards were invited to participate in the study. Appropriateness was defined using four criteria: clarity, importance, relevance and usefulness. The modified Delphi technique was selected as a structured method to develop consensus. RAND definition for consensus was used. In the second round, feedback on the first round was provided. The study did not require Research Ethics approval. KEY FINDINGS: Sixty-five hospital pharmacists completed the first round Delphi, and 59 of them completed the second round. Their experience ranged from three to 33 years with an average of 16.6 years. Fifty-five indicators were sent to the panel after the pilot study. Each of the two rounds took approximately 8 weeks to be completed. Forty-one indicators reached consensus to be appropriate. Fourteen indicators did not reach consensus. CONCLUSIONS: The Delphi technique was very effective for enhancing the panel participation as noticed in their responses both in the first and second rounds. Forty-one indicators achieved consensus as being appropriate to evaluate the MR process. These indicators could be used to assess the process and hence improve the quality of the patient care on hospital admission. The indicators need to be used in practice.
